We’re excited to share the video from our recent webinar featuring Chris Lipinski and Barry Bunin
Recorded September 13, 2018:
Whether you love or hate the “Lipinski Rule of 5 (Ro5)” you certainly can’t ignore it (or what Chris has to say about it). Lipinski’s rule has become the established benchmark by which almost all drug discovery analyses are now compared.
Discussion Points:
- Going beyond the Rules of 5
- New technologies to better assess the quality of screening data
- Evolutionary development of natural product antibiotics
- Plus topics you would not expect, like how scientists can (and should) respond to the growing opioid addiction crisis – which has actually lowered life expectancy in America
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities.
CDD Vault: Complexity Simplified
Other posts you might be interested in
View All Posts
CDD Blog
19 min
June 6, 2025
Synthetic Lethality in Precision Oncology: Integrating AI-Driven Discovery with Data Management Platforms
Read More
CDD Blog
29 min
June 4, 2025
How to Choose the Right ELN or LIMS for Early-Stage Drug Discovery
Read More
CDD Blog
10 min
June 3, 2025
Chemical Registration in Drug Discovery
Read More